Loading clinical trials...
Loading clinical trials...
Many tumor cells, in contrast to normal cells, have been shown to require the amino acid glutamine to produce energy for growth and survival. To exploit the dependence of tumors on glutamine, CB-839, ...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Calithera Biosciences, Inc
NCT07500441 · Acute Myeloid Leukemia (AML)
NCT05768932 · Advanced Solid Tumor, TNBC - Triple-Negative Breast Cancer, and more
NCT05756777 · Acute Myeloid Leukemia (AML)
NCT07451912 · Acute Myeloid Leukemia (AML), CEBPA Mutation, and more
NCT06660368 · Relapsed or Refractory Acute Myeloid Leukemia (AML)
Colorado Blood Cancer Institute
Denver, Colorado
Northwestern University Feinberg School of Medicine
Chicago, Illinois
Roswell Park Cancer Institute
Buffalo, New York
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions